X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1009) 1009
female (1008) 1008
ovarian neoplasms - drug therapy (636) 636
cystadenocarcinoma, serous - drug therapy (634) 634
middle aged (626) 626
oncology (622) 622
ovarian neoplasms - pathology (579) 579
index medicus (522) 522
cystadenocarcinoma, serous - pathology (515) 515
aged (504) 504
ovarian cancer (454) 454
adult (438) 438
chemotherapy (336) 336
cancer (335) 335
prognosis (334) 334
neoplasm staging (321) 321
antineoplastic combined chemotherapy protocols - therapeutic use (320) 320
carcinoma (298) 298
obstetrics & gynecology (297) 297
survival rate (234) 234
cystadenocarcinoma, serous - genetics (227) 227
ovarian neoplasms - genetics (212) 212
ovarian neoplasms - metabolism (211) 211
cystadenocarcinoma, serous - metabolism (209) 209
aged, 80 and over (195) 195
retrospective studies (192) 192
ovarian neoplasms - mortality (185) 185
cystadenocarcinoma, serous - mortality (183) 183
cystadenocarcinoma, serous - surgery (171) 171
treatment outcome (167) 167
ovarian neoplasms - surgery (165) 165
survival (160) 160
follow-up studies (159) 159
paclitaxel - administration & dosage (152) 152
adenocarcinoma, clear cell - drug therapy (145) 145
cisplatin (141) 141
paclitaxel (141) 141
carboplatin - administration & dosage (137) 137
neoplasm recurrence, local - drug therapy (136) 136
endometrial neoplasms - drug therapy (134) 134
chemotherapy, adjuvant (120) 120
neoplasm grading (120) 120
drug resistance, neoplasm (119) 119
disease-free survival (118) 118
endometrial neoplasms - pathology (115) 115
expression (115) 115
cell line, tumor (113) 113
tumors (113) 113
cisplatin - administration & dosage (112) 112
adenocarcinoma, mucinous - drug therapy (110) 110
adenocarcinoma, clear cell - pathology (108) 108
immunohistochemistry (108) 108
antineoplastic agents - therapeutic use (103) 103
neoplasm recurrence, local - pathology (103) 103
animals (102) 102
combined modality therapy (99) 99
peritoneal neoplasms - drug therapy (96) 96
research (96) 96
care and treatment (92) 92
cystadenocarcinoma, papillary - drug therapy (91) 91
carboplatin (90) 90
analysis (88) 88
mice (88) 88
pathology (86) 86
carcinoma, endometrioid - drug therapy (84) 84
cystadenocarcinoma, serous - secondary (83) 83
ovarian carcinoma (83) 83
adenocarcinoma, mucinous - pathology (79) 79
genetic aspects (79) 79
tumor cells, cultured (79) 79
breast-cancer (78) 78
obstetrics and gynecology (78) 78
surgery (78) 78
gene expression (75) 75
gene expression regulation, neoplastic (75) 75
mutation (74) 74
therapy (73) 73
article (72) 72
hematology, oncology and palliative medicine (71) 71
biomarkers, tumor - metabolism (70) 70
gynecologic-oncology-group (70) 70
adenocarcinoma, clear cell - mortality (67) 67
health aspects (67) 67
metastasis (67) 67
adenocarcinoma (66) 66
apoptosis (65) 65
survival analysis (65) 65
endometrial cancer (64) 64
cystadenocarcinoma, serous - therapy (63) 63
endometrial neoplasms - mortality (63) 63
ovarian neoplasms - therapy (60) 60
uterine neoplasms - drug therapy (60) 60
cells (59) 59
endocrine system diseases (59) 59
peritoneal neoplasms - pathology (59) 59
carcinoma, papillary - drug therapy (58) 58
cyclophosphamide (57) 57
cyclophosphamide - administration & dosage (57) 57
adenocarcinoma, mucinous - mortality (56) 56
antineoplastic combined chemotherapy protocols - adverse effects (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (936) 936
Chinese (35) 35
Japanese (28) 28
Russian (6) 6
German (5) 5
French (4) 4
Hungarian (3) 3
Italian (3) 3
Bulgarian (1) 1
Hebrew (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1579 - 1589
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 34, pp. 4015 - 4022
Journal Article
Journal Article
The Journal of Pathology, ISSN 0022-3417, 05/2010, Volume 221, Issue 1, pp. 49 - 56
Journal Article
Journal Article
Cancer Research, ISSN 0008-5472, 06/2012, Volume 72, Issue 11, pp. 2701 - 2704
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2654 - 2663
Purpose The frequency of BRCA1 and BRCA2 germ-line mutations in women with ovarian cancer is unclear; reports vary from 3% to 27%. The impact of germ-line... 
POLY(ADP-RIBOSE) POLYMERASE | CLEAR-CELL | ONCOLOGY | RESISTANCE | IMPROVED SURVIVAL | HOMOLOGOUS RECOMBINATION | CARCINOMA | CARRIERS | TUMORS | CHEMOTHERAPY | FEATURES | Medical History Taking | Recurrence | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - drug therapy | Case-Control Studies | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - genetics | Aged, 80 and over | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Carcinoma, Endometrioid - genetics | Kaplan-Meier Estimate | Mutation Rate | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Australia - epidemiology | Ovarian Neoplasms - epidemiology | Disease-Free Survival | Point Mutation | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Aged | Platinum Compounds - administration & dosage | Neoplasm Staging | Adenocarcinoma, Clear Cell - genetics | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Original Reports | Gynecologic Cancer | Gync21 | Gync15
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2015, Volume 21, Issue 7, pp. 1574 - 1582
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2015, Volume 33, Issue 22, pp. 2457 - 2463
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e61537
Accumulating epidemiological evidence shows that obesity is associated with an increased risk of several types of adult cancers, including endometrial cancer.... 
BREAST-CANCER | TARGETED THERAPY | MULTIDISCIPLINARY SCIENCES | ENDOMETRIAL CANCER-CELLS | RESISTANCE | RISK | RECEPTOR GENE | MODEL | EXPRESSION | CHEMOTHERAPY | GROWTH-FACTOR-I | Cell Cycle - genetics | Receptor, IGF Type 1 - metabolism | Insulin-Like Growth Factor I - pharmacology | Metformin - therapeutic use | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Uterine Neoplasms - pathology | Humans | Cell Survival - genetics | Apoptosis - genetics | Glycogen Synthase Kinase 3 beta | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - drug therapy | Promoter Regions, Genetic - genetics | Uterine Neoplasms - enzymology | Receptor, Insulin - genetics | Adenylate Kinase - metabolism | Female | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Cell Survival - drug effects | Metformin - pharmacology | Tumor Suppressor Protein p53 - metabolism | Down-Regulation - drug effects | Glycogen Synthase Kinase 3 - metabolism | Receptor, IGF Type 1 - genetics | Cystadenocarcinoma, Serous - enzymology | Cell Movement - drug effects | Insulin - metabolism | Signal Transduction - drug effects | Uterine Neoplasms - drug therapy | Cell Line, Tumor | Endometrial Neoplasms - pathology | Receptor, Insulin - metabolism | Cell Proliferation - drug effects | Forkhead Box Protein O1 | Cell Cycle - drug effects | Forkhead Transcription Factors | Insulin-Like Growth Factor I - metabolism | Type 2 diabetes | Obesity | Carcinoma | Endometrial cancer | Insulin resistance | Metformin | Tumor proteins | Health aspects | Epidemiology | Diabetes therapy | Cancer | Cell proliferation | Hyperinsulinemia | Insulin-like growth factor I | p53 Protein | Insulin-like growth factors | Kinases | Cancer therapies | Ovarian cancer | Signal transduction | Cell growth | Pathways | Uterus | Growth factors | Endometrium | Diabetes mellitus | Health risks | Insulin | Signaling | Cell lines | Cell migration | Apoptosis
Journal Article
13.